These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 10629934
1. [Magnetic resonance angiography in multiple sclerosis]. Pati DV, Vorobeĭchik G. Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):53-7. PubMed ID: 10629934 [No Abstract] [Full Text] [Related]
2. [Current data on interferon therapy of multiple sclerosis in patients at developmental age]. Smigielska-Kuzia J, Sobaniec W, Kułak W, Boćkowski L, Wołk M, Sołowiej E, Artemowicz B. Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S45-51. PubMed ID: 15045867 [Abstract] [Full Text] [Related]
3. The use of interferon beta in relapsing-remitting multiple sclerosis. Etheridge LJ, Beverley DW, Ferrie C, McManus E. Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086 [Abstract] [Full Text] [Related]
4. A rare 'palisading' enhancing pattern of multiple sclerosis. Huang CF, Lo CP, Tseng CY, Chen YC. Eur Neurol; 2012 Aug; 67(3):161. PubMed ID: 22261728 [No Abstract] [Full Text] [Related]
5. [Cognitive disturbances and attempts of their correction in multiple sclerosis]. Shmidt TE. Zh Nevrol Psikhiatr Im S S Korsakova; 2005 Aug; 105(9):54-6. PubMed ID: 16252387 [No Abstract] [Full Text] [Related]
6. Multiple sclerosis: what have we learned from magnetic resonance imaging studies? Khoury SJ, Weiner HL. Arch Intern Med; 1998 Mar 23; 158(6):565-73. PubMed ID: 9521220 [Abstract] [Full Text] [Related]
7. The curious incident of disability in multiple sclerosis trials. Coles A. Lancet Neurol; 2006 Nov 23; 5(11):899-900. PubMed ID: 17052654 [No Abstract] [Full Text] [Related]
8. Interferon beta treatment in relapsing-remitting multiple sclerosis. A review. Grigoriadis N. Clin Neurol Neurosurg; 2002 Jul 23; 104(3):251-8. PubMed ID: 12127664 [No Abstract] [Full Text] [Related]
9. [A short history of beta-interferon therapy of multiple sclerosis]. Stock G, Horowski R. Med Klin (Munich); 2001 Sep 15; 96 Suppl 1():3-9. PubMed ID: 11603113 [Abstract] [Full Text] [Related]
11. [Treatment with beta-interferon should be started already after the first attack of MS]. Söderström M. Lakartidningen; 2001 Feb 07; 98(6):587-90, 593-4. PubMed ID: 11475246 [No Abstract] [Full Text] [Related]
12. Glatiramer and suspected multiple sclerosis. No proven advantage. Prescrire Int; 2010 Aug 07; 19(108):160. PubMed ID: 20941852 [No Abstract] [Full Text] [Related]
15. Seeing injectable ms therapies differently: they are more similar than different. Johnson KP, Fox RJ, Arnold DL. Neurology; 2010 Feb 23; 74(8):702. PubMed ID: 20177129 [No Abstract] [Full Text] [Related]
19. Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial. Wolansky LJ, Haghighi MH, Sevdalis E, Cook SD, Sethi N, Liu J, Joseph G, Tulloch K, Cadavid D. J Neuroimaging; 2005 Jul 23; 15(3):289-90. PubMed ID: 15951416 [No Abstract] [Full Text] [Related]
20. [The interferon beta therapy after the first clinical episode of demyelination in multiple sclerosis]. Demina TL, Khachanova NV, Davydovskaia MV. Zh Nevrol Psikhiatr Im S S Korsakova; 2006 Jul 23; 106(3):15-9. PubMed ID: 16608106 [Abstract] [Full Text] [Related] Page: [Next] [New Search]